News

Our Weekly News digest clarifies and condenses the key developments and talking points in life sciences R&D. We identify and summarise the five top stories in quick-read format, so you have a full, clear and balanced picture of the latest advancements spanning diverse therapeutic areas and key development phases.
MIT Develop New Method of AAV Manufacture for Gene Therapy
GSK Acquires Rights to ADC for Prostate Cancer for £268m
Gene Therapy Delivers Lasting Immune Protection to 59 Children with ADA-SCID
COVID Vaccines Mount Anti-Cancer Immune Response, Say Researchers in Boost for Universal Cancer Vaccine
See Antibody Binding in 3D: How Cryo-EM Epitope Mapping Accelerates Antibody Discovery
Bristol Myers Squibb Buys Orbital Therapeutics in $1.5b Deal
Boehringer Ingelheim to Enter $991 Million Partnership with AimedBio for ADC Targeting Broad Spectrum of Cancers
Three CGT Draft Guidance Documents Released by the FDA
Strategic Decisions in Early R&D for Antibody Research & Discovery: A Forward-Looking Perspective
Clinical Challenges in the Application of Cell Engagers: Current Hurdles and Future Horizons
mRNA Allergy Vaccine ‘A Potential Breakthrough for Millions’, says Nobel Laureate
Engineering the Future of ADCs: Innovation, Efficacy, and Clinical Integration
Analysis of Neuropeptide Function Using New Tool
“Dawn of a new age”: RNA Silencing Therapy Slows Huntington’s Disease by 75% in Clinical Trial
Topical Gene Therapy for Rare Skin Disease Gets Expanded Label
Promising Reports from First-in-Human Trial for ADC SCLC
Report Details Bispecific Antibody Drug Conjugate Market Ripe with Key Partnerships
Clonogenic Hepatocytes are Important Targets for Paediatric Gene Therapies, say Researchers
Double Strike for Akeso’s mAbs in Phase III Treating Atopic Dermatitis & Ankylosing Spondylitis